Quantile Health has developed a cloud-based reimbursement platform that enables payers to enter subscription-based access agreements with manufacturers of gene therapies. This platform addresses the challenge of high-cost gene therapies by providing a structured payment solution that enhances patient access while managing financial risks for health plans.
Funding
$7.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The increasing number of high-cost gene therapies presents a challenge for payers, who must balance the potential benefits of these treatments against budgetary constraints. Traditional actuarial methods are often inadequate for managing the financial risks associated with these novel, ultra-rare therapies, potentially limiting patient access. Pharmaceutical companies also face difficulties in securing coverage and reimbursement for these therapies, leading to delays in market access.
Solution
Quantile Health offers an AI-powered reimbursement platform designed to facilitate subscription-based access agreements between payers and manufacturers of gene therapies. The platform provides real-time market insights, enabling pharmaceutical companies to optimize their commercialization strategies and navigate market entry challenges more effectively. By creating a structured payment solution, Quantile Health aims to improve patient access to transformative medicines while helping health plans manage the financial risks associated with gene therapies. The platform helps payers balance drug efficacy with limited budgets, and helps manufacturers streamline the process of securing payer coverage.
Target Audience
The primary target audience includes pharmaceutical companies specializing in gene therapies and payers, such as health plans, seeking to manage the financial impact of these high-cost treatments.
Features
- AI-powered analytics for real-time market insights related to gene therapies.
- Platform facilitates subscription-based access agreements between payers and manufacturers.
- Structured payment solutions designed to manage financial risks for health plans.
- Streamlined data-driven insights to improve market access strategies.